Housing for an autoinjector
Latest GlaxoSmithKline Intellectual Property Management Limited Patents:
- High Concentratioin Anti-BLYS Pharmaceutical Formulations
- High concentration anti-blys pharmaceutical formulations
- Dosing Regimen of Combination of Anti-CD20 and Anti-BLyS Antibodies
- Dosing regimen of combination of ANTICD20 and anti-BlyS antibodies
- Anti-BAFF Antibodies for use in a Method of Treatment of Long Covid and/or Post-Acute Sequelae SARS-CoV-2 Infection (PASC)
The portions of the drawings appearing in broken line are for environment only and do not form a part of the claimed design. The shaded portions of
Claims
We claim the ornamental design for a housing for an autoinjector, as shown and described.
4636202 | January 13, 1987 | Lowin |
D551295 | September 18, 2007 | Chen |
D628632 | December 7, 2010 | Liu |
D629509 | December 21, 2010 | Julian et al. |
D641078 | July 5, 2011 | Morgan |
8057433 | November 15, 2011 | Cuca |
D650070 | December 6, 2011 | Mori |
D660419 | May 22, 2012 | Morgan |
D671638 | November 27, 2012 | Young |
D703810 | April 29, 2014 | Sanders |
D726902 | April 14, 2015 | McLoughlin |
D735322 | July 28, 2015 | Tyce et al. |
D735848 | August 4, 2015 | Dubuc |
D739932 | September 29, 2015 | Ratjen |
D755956 | May 10, 2016 | McLoughlin |
20090182284 | July 16, 2009 | Morgan |
20140330203 | November 6, 2014 | McLoughlin |
141659 | August 2000 | AU |
145550 | October 2001 | AU |
314895 | June 2006 | AU |
304742 | June 2007 | AU |
304743 | June 2007 | AU |
305020 | June 2007 | AU |
314700 | June 2007 | AU |
314701 | June 2007 | AU |
314702 | June 2007 | AU |
314703 | June 2007 | AU |
314704 | June 2007 | AU |
314705 | June 2007 | AU |
314706 | June 2007 | AU |
315948 | September 2007 | AU |
319680 | May 2008 | AU |
320751 | August 2008 | AU |
320752 | August 2008 | AU |
320753 | August 2008 | AU |
321891 | November 2008 | AU |
323564 | January 2009 | AU |
331790 | July 2010 | AU |
340784 | February 2012 | AU |
345700 | November 2012 | AU |
346919 | February 2013 | AU |
350546 | September 2013 | AU |
350719 | September 2013 | AU |
350720 | September 2013 | AU |
350721 | September 2013 | AU |
358813 | March 2014 | AU |
358814 | March 2014 | AU |
358815 | March 2014 | AU |
358816 | March 2014 | AU |
612-2009 | September 2008 | CL |
613-2009 | September 2008 | CL |
874-2009 | October 2008 | CL |
875-2009 | October 2008 | CL |
288-2013 | August 2012 | CL |
289-2013 | August 2012 | CL |
000007893-0002 | April 2003 | EM |
000837653-0001 | December 2007 | EM |
000981964-0001 | August 2008 | EM |
000981964-0002 | August 2008 | EM |
000981964-0003 | August 2008 | EM |
000981964-0004 | August 2008 | EM |
001798869-0001 | December 2010 | EM |
2274032 | January 2011 | EP |
D2048258 | June 1995 | GB |
D2079926 | December 1998 | GB |
D3006400 | August 2002 | GB |
D3006401 | August 2002 | GB |
D3006884 | September 2002 | GB |
D3006886 | September 2002 | GB |
D3006887 | September 2002 | GB |
D3006888 | September 2002 | GB |
D3006889 | September 2002 | GB |
D3006890 | September 2002 | GB |
D3006891 | September 2002 | GB |
D3006892 | September 2002 | GB |
D3006893 | September 2002 | GB |
D3006894 | September 2002 | GB |
D3006895 | September 2002 | GB |
D3006896 | September 2002 | GB |
D3006897 | September 2002 | GB |
D3026067 | September 2006 | GB |
D4001969 | March 2007 | GB |
D4001970 | March 2007 | GB |
D4034270 | February 2014 | GB |
D4035008 | March 2014 | GB |
76137 | September 2008 | RU |
D141022 | June 2011 | TW |
D164872 | December 2014 | TW |
WO 2006/032385 | March 2006 | WO |
WO 2014/033195 | March 2014 | WO |
Type: Grant
Filed: May 8, 2014
Date of Patent: Jun 27, 2017
Assignee: GlaxoSmithKline Intellectual Property Management Limited (Brentford, Middlesex)
Inventors: Mark Anthony Cox (Ware), Joseph John Fire (Rockville, MD), Michelle Nicole Kwasny (Cambridge, MA), Scott Robert Mackie (Cambridge, MA), Robert John McCaffrey (Hollis, NH), Jason Lee Robinson (Cambridge, MA), Gerd Schmieta (Boston, MA)
Primary Examiner: David Muller
Application Number: 29/490,267